A Reassessment of a Classic Neuroprotective Combination Therapy for Spinal Cord Injured Rats: LPS/pregnenolone/indomethacin

Overview

Journal Exp Neurol

Specialty Neurology

Date 2011 Dec 20

PMID 22177997

Citations 16

Authors

Phillip G Popovich

C Amy Tovar

Ping Wei

Lesley Fisher

Lyn B Jakeman

D Michele Basso

Affiliations

Soon will be listed here.

Abstract

These experiments were completed as part of an NIH-NINDS contract entitled "Facilities of Research Excellence-Spinal Cord Injury (FORE-SCI)-Replication". Our goal was to replicate data from a paper published by Dr. Lloyd Guth and colleagues in which combined injections of lipopolysaccharide, indomethacin and pregnenolone (referred to herein as LIP therapy) conferred marked neuroprotection in a pre-clinical model of spinal cord injury (SCI). Specifically, post-injury injection of the combination LIP therapy was found to significantly reduce tissue damage at/nearby the site of injury and significantly improve recovery of locomotor function. In this report, we confirm the primary observations made by Guth et al., however, the effects of LIP treatment were modest. Specifically, LIP treatment improved myelin and axon sparing, axonal sprouting while reducing lesion cavitation. However, spontaneous recovery of locomotion, as assessed using historical (Tarlov scoring) and more current rating scales (i.e., BBB scoring), was not affected by LIP treatment. Instead, more refined parameters of functional recovery (paw placement accuracy during grid walk) revealed a significant effect of treatment. Possible explanations for the neuroprotective effects of LIP therapy are described along with reasons why the magnitude of neuroprotection may have differed between this study and that of Guth and colleagues.

Citing Articles

Administration of low intensity vibration and a RANKL inhibitor, alone or in combination, reduces bone loss after spinal cord injury-induced immobilization in rats.

Peng Y, Bramlett H, Dietrich W, Marcillo A, Sanchez-Molano J, Furones-Alonso O Bone Rep. 2024; 23:101808.

PMID: 39429803 PMC: 11489065. DOI: 10.1016/j.bonr.2024.101808.

α-Gal Nanoparticles in CNS Trauma: II. Immunomodulation Following Spinal Cord Injury (SCI) Improves Functional Outcomes.

Gopalakrishnan B, Galili U, Saenger M, Burket N, Koss W, Lokender M Tissue Eng Regen Med. 2024; 21(3):437-453.

PMID: 38308742 PMC: 10987462. DOI: 10.1007/s13770-023-00616-y.

Low-dose Lipopolysaccharide Alleviates Spinal Cord Injury-induced Neuronal Inflammation by Inhibiting microRNA-429-mediated Suppression of PI3K/AKT/Nrf2 Signaling.

Li W, Tang T, Yao S, Zhong S, Fan Q, Zou T Mol Neurobiol. 2023; 61(1):294-307.

PMID: 37605094 DOI: 10.1007/s12035-023-03483-9.

Delayed viral vector mediated delivery of neurotrophin-3 improves skilled hindlimb function and stability after thoracic contusion.

Sydney-Smith J, Koltchev A, Moon L, Warren P Exp Neurol. 2022; 360:114278.

PMID: 36455639 PMC: 10227192. DOI: 10.1016/j.expneurol.2022.114278.

Enhancing Functional Recovery Through Intralesional Application of Extracellular Vesicles in a Rat Model of Traumatic Spinal Cord Injury.

Romanelli P, Bieler L, Heimel P, Skokic S, Jakubecova D, Kreutzer C Front Cell Neurosci. 2022; 15:795008.

PMID: 35046776 PMC: 8762366. DOI: 10.3389/fncel.2021.795008.

References

Fu Q, Hue J, Li S . Nonsteroidal anti-inflammatory drugs promote axon regeneration via RhoA inhibition. J Neurosci. 2007; 27(15):4154-64. PMC: 6672522. DOI: 10.1523/JNEUROSCI.4353-06.2007. View

Davis A, Campbell S, Wilainam P, Anthony D . Post-conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord: a potential neuroprotective treatment. Eur J Neurosci. 2005; 22(10):2441-50. DOI: 10.1111/j.1460-9568.2005.04447.x. View

Rock K, Latz E, Ontiveros F, Kono H . The sterile inflammatory response. Annu Rev Immunol. 2010; 28:321-42. PMC: 4315152. DOI: 10.1146/annurev-immunol-030409-101311. View

Wrathall J, Pettegrew R, Harvey F . Spinal cord contusion in the rat: production of graded, reproducible, injury groups. Exp Neurol. 1985; 88(1):108-22. DOI: 10.1016/0014-4886(85)90117-7. View

TARLOV I, Klinger H . Spinal cord compression studies. II. Time limits for recovery after acute compression in dogs. AMA Arch Neurol Psychiatry. 1954; 71(3):271-90. View

WINDLE W, CHAMBERS W . Regeneration in the spinal cord of the cat and dog. J Comp Neurol. 1950; 93(2):241-57. DOI: 10.1002/cne.900930206. View

Kigerl K, Popovich P . Toll-like receptors in spinal cord injury. Curr Top Microbiol Immunol. 2009; 336:121-36. DOI: 10.1007/978-3-642-00549-7_7. View

Loy D, Magnuson D, Zhang Y, Onifer S, Mills M, Cao Q . Functional redundancy of ventral spinal locomotor pathways. J Neurosci. 2002; 22(1):315-23. PMC: 6757623. View

FLEISCHMAN R, McCracken D, Forbes W . Adynamic ileus in the rat induced by chloral hydrate. Lab Anim Sci. 1977; 27(2):238-43. View

10.

Zhang Z, Guth L . Experimental spinal cord injury: Wallerian degeneration in the dorsal column is followed by revascularization, glial proliferation, and nerve regeneration. Exp Neurol. 1997; 147(1):159-71. DOI: 10.1006/exnr.1997.6590. View

11.

Hanisch U, Johnson T, Kipnis J . Toll-like receptors: roles in neuroprotection?. Trends Neurosci. 2008; 31(4):176-82. DOI: 10.1016/j.tins.2008.01.005. View

12.

Lehnardt S, Massillon L, Follett P, Jensen F, Ratan R, Rosenberg P . Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A. 2003; 100(14):8514-9. PMC: 166260. DOI: 10.1073/pnas.1432609100. View

13.

Popovich P, Lemeshow S, Gensel J, Tovar C . Independent evaluation of the effects of glibenclamide on reducing progressive hemorrhagic necrosis after cervical spinal cord injury. Exp Neurol. 2010; 233(2):615-22. PMC: 3272125. DOI: 10.1016/j.expneurol.2010.11.016. View

14.

Ahmed S, He Y, Nassief A, Xu J, Xu X, Hsu C . Effects of lipopolysaccharide priming on acute ischemic brain injury. Stroke. 2000; 31(1):193-9. DOI: 10.1161/01.str.31.1.193. View

15.

Schwab J, Conrad S, Elbert T, Trautmann K, Meyermann R, Schluesener H . Lesional RhoA+ cell numbers are suppressed by anti-inflammatory, cyclooxygenase-inhibiting treatment following subacute spinal cord injury. Glia. 2004; 47(4):377-86. DOI: 10.1002/glia.20031. View

16.

Guth L, Zhang Z, DiProspero N, Joubin K, Fitch M . Spinal cord injury in the rat: treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function. Exp Neurol. 1994; 126(1):76-87. DOI: 10.1006/exnr.1994.1043. View

17.

Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R . Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol. 2007; 9(9):1081-8. DOI: 10.1038/ncb1629. View

18.

Yang Q, Lu F, Zhou Y, Wang L, Zhong Q, Lin S . HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab. 2010; 31(2):593-605. PMC: 3049514. DOI: 10.1038/jcbfm.2010.129. View

19.

Kigerl K, Lai W, Rivest S, Hart R, Satoskar A, Popovich P . Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem. 2007; 102(1):37-50. DOI: 10.1111/j.1471-4159.2007.04524.x. View

20.

Scheff S, Saucier D, Cain M . A statistical method for analyzing rating scale data: the BBB locomotor score. J Neurotrauma. 2002; 19(10):1251-60. DOI: 10.1089/08977150260338038. View